Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease.

× No keyword cloud information.

6 in total

1. PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

Authors: H Hampel; S E O'Bryant; J I Castrillo; C Ritchie; K Rojkova; K Broich; N Benda; R Nisticò; R A Frank; B Dubois; V Escott-Price; S Lista
Journal: J Prev Alzheimers Dis Date: 2016-09-06

Review 2. Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Authors: Colleen J Maxwell; Kathryn Stock; Dallas Seitz; Nathan Herrmann
Journal: Can J Psychiatry Date: 2014-12 Impact factor: 4.356

3. Souvenaid®: a new approach to management of early Alzheimer's disease.

Authors: C W Ritchie; J Bajwa; G Coleman; K Hope; R W Jones; M Lawton; M Marven; P Passmore
Journal: J Nutr Health Aging Date: 2014-03 Impact factor: 4.075

Review 4. Primary prevention of Alzheimer's disease: is it an attainable goal?

Authors: Jee-Young Han; Seol-Heui Han
Journal: J Korean Med Sci Date: 2014-07-11 Impact factor: 2.153

5. A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia.

Authors: Laura M Gault; Craig W Ritchie; Weining Z Robieson; Yili Pritchett; Ahmed A Othman; Robert A Lenz
Journal: Alzheimers Dement (N Y) Date: 2015-06-23

6. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.

Authors: Laura M Gault; Robert A Lenz; Craig W Ritchie; Andreas Meier; Ahmed A Othman; Qi Tang; Scott Berry; Yili Pritchett; Weining Z Robieson
Journal: Alzheimers Res Ther Date: 2016-10-18 Impact factor: 6.982

6 in total